InvestorsHub Logo
Followers 3
Posts 295
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Monday, 03/27/2023 5:06:53 PM

Monday, March 27, 2023 5:06:53 PM

Post# of 572
Canaccord Genuity has decided to maintain its Buy rating of Aptose Biosciences (NASDAQ:APTO) and lower its price target from $13.00 to $8.00.
Who wouldn't be happy with $8/share?
https://markets.businessinsider.com/news/stocks/canaccord-genuity-maintains-buy-rating-for-aptose-biosciences-here-s-what-you-need-to-know-1032194902
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News